Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation

Yoji Sato, Helen Kiriazis, Atsuko Yatani, Albrecht G. Schmidt, Harvey Hahn, Donald G. Ferguson, Hidenori Sako, Sayaka Mitarai, Ritsu Honda, Laurence Mesnard-Rouiller, Konrad F. Frank, Beate Beyermann, Guangyu Wu, Kannosuke Fujimori, Gerald W. Dorn, Evangelia G. Kranias

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Cardiac-specific overexpression of murine cardiac calsequestrin results in depressed cardiac contractile parameters, low Ca2+-induced Ca 2+ release from sarcoplasmic reticulum (SR) and cardiac hypertrophy in transgenic mice. To test the hypothesis that inhibition of phospholamban activity may rescue some of these phenotypic alterations, the calsequestrin overexpressing mice were cross-bred with phospholamban-knockout mice. Phospholamban ablation in calsequestrin overexpressing mice led to reversal of the depressed cardiac contractile parameters in Langendorff-perfused hearts or in vivo. This was associated with increases of SR Ca2+ storage, assessed by caffeine-induced Na+-Ca2+ exchanger currents. The inactivation time of the L-type Ca2+ current (ICa) which has an inverse correlation with Ca2+-induced SR Ca 2+ release, and the relation between the peak current density and half-inactivation time were also normalized, indicating a restoration in the ability of ICa to trigger SR Ca2+ release. The prolonged action potentials in calsequestrin overexpressing cardiomyocytes also reversed to normal upon phospholamban ablation. Furthermore, ablation of phospholamban restored the expression levels of atrial natriuretic factor and α-skeletal actin mRNA as well as ventricular myocyte size. These results indicate that attenuation of phospholamban function may prevent or overcome functional and remodeling defects in hypertrophied hearts.

Original languageEnglish (US)
Pages (from-to)9392-9399
Number of pages8
JournalJournal of Biological Chemistry
Volume276
Issue number12
DOIs
StatePublished - Mar 23 2001
Externally publishedYes

Fingerprint

Calsequestrin
Ablation
Muscle Cells
Hypertrophy
Myocardium
Sarcoplasmic Reticulum
Cardiomegaly
Atrial Natriuretic Factor
Caffeine
Cardiac Myocytes
Knockout Mice
Transgenic Mice
Action Potentials
Restoration
phospholamban
Actins
Current density
Messenger RNA
Defects

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Sato, Y., Kiriazis, H., Yatani, A., Schmidt, A. G., Hahn, H., Ferguson, D. G., ... Kranias, E. G. (2001). Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation. Journal of Biological Chemistry, 276(12), 9392-9399. https://doi.org/10.1074/jbc.M006889200

Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation. / Sato, Yoji; Kiriazis, Helen; Yatani, Atsuko; Schmidt, Albrecht G.; Hahn, Harvey; Ferguson, Donald G.; Sako, Hidenori; Mitarai, Sayaka; Honda, Ritsu; Mesnard-Rouiller, Laurence; Frank, Konrad F.; Beyermann, Beate; Wu, Guangyu; Fujimori, Kannosuke; Dorn, Gerald W.; Kranias, Evangelia G.

In: Journal of Biological Chemistry, Vol. 276, No. 12, 23.03.2001, p. 9392-9399.

Research output: Contribution to journalArticle

Sato, Y, Kiriazis, H, Yatani, A, Schmidt, AG, Hahn, H, Ferguson, DG, Sako, H, Mitarai, S, Honda, R, Mesnard-Rouiller, L, Frank, KF, Beyermann, B, Wu, G, Fujimori, K, Dorn, GW & Kranias, EG 2001, 'Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation', Journal of Biological Chemistry, vol. 276, no. 12, pp. 9392-9399. https://doi.org/10.1074/jbc.M006889200
Sato, Yoji ; Kiriazis, Helen ; Yatani, Atsuko ; Schmidt, Albrecht G. ; Hahn, Harvey ; Ferguson, Donald G. ; Sako, Hidenori ; Mitarai, Sayaka ; Honda, Ritsu ; Mesnard-Rouiller, Laurence ; Frank, Konrad F. ; Beyermann, Beate ; Wu, Guangyu ; Fujimori, Kannosuke ; Dorn, Gerald W. ; Kranias, Evangelia G. / Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 12. pp. 9392-9399.
@article{99dd7b4a17f14e99b1b0361722865c25,
title = "Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation",
abstract = "Cardiac-specific overexpression of murine cardiac calsequestrin results in depressed cardiac contractile parameters, low Ca2+-induced Ca 2+ release from sarcoplasmic reticulum (SR) and cardiac hypertrophy in transgenic mice. To test the hypothesis that inhibition of phospholamban activity may rescue some of these phenotypic alterations, the calsequestrin overexpressing mice were cross-bred with phospholamban-knockout mice. Phospholamban ablation in calsequestrin overexpressing mice led to reversal of the depressed cardiac contractile parameters in Langendorff-perfused hearts or in vivo. This was associated with increases of SR Ca2+ storage, assessed by caffeine-induced Na+-Ca2+ exchanger currents. The inactivation time of the L-type Ca2+ current (ICa) which has an inverse correlation with Ca2+-induced SR Ca 2+ release, and the relation between the peak current density and half-inactivation time were also normalized, indicating a restoration in the ability of ICa to trigger SR Ca2+ release. The prolonged action potentials in calsequestrin overexpressing cardiomyocytes also reversed to normal upon phospholamban ablation. Furthermore, ablation of phospholamban restored the expression levels of atrial natriuretic factor and α-skeletal actin mRNA as well as ventricular myocyte size. These results indicate that attenuation of phospholamban function may prevent or overcome functional and remodeling defects in hypertrophied hearts.",
author = "Yoji Sato and Helen Kiriazis and Atsuko Yatani and Schmidt, {Albrecht G.} and Harvey Hahn and Ferguson, {Donald G.} and Hidenori Sako and Sayaka Mitarai and Ritsu Honda and Laurence Mesnard-Rouiller and Frank, {Konrad F.} and Beate Beyermann and Guangyu Wu and Kannosuke Fujimori and Dorn, {Gerald W.} and Kranias, {Evangelia G.}",
year = "2001",
month = "3",
day = "23",
doi = "10.1074/jbc.M006889200",
language = "English (US)",
volume = "276",
pages = "9392--9399",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation

AU - Sato, Yoji

AU - Kiriazis, Helen

AU - Yatani, Atsuko

AU - Schmidt, Albrecht G.

AU - Hahn, Harvey

AU - Ferguson, Donald G.

AU - Sako, Hidenori

AU - Mitarai, Sayaka

AU - Honda, Ritsu

AU - Mesnard-Rouiller, Laurence

AU - Frank, Konrad F.

AU - Beyermann, Beate

AU - Wu, Guangyu

AU - Fujimori, Kannosuke

AU - Dorn, Gerald W.

AU - Kranias, Evangelia G.

PY - 2001/3/23

Y1 - 2001/3/23

N2 - Cardiac-specific overexpression of murine cardiac calsequestrin results in depressed cardiac contractile parameters, low Ca2+-induced Ca 2+ release from sarcoplasmic reticulum (SR) and cardiac hypertrophy in transgenic mice. To test the hypothesis that inhibition of phospholamban activity may rescue some of these phenotypic alterations, the calsequestrin overexpressing mice were cross-bred with phospholamban-knockout mice. Phospholamban ablation in calsequestrin overexpressing mice led to reversal of the depressed cardiac contractile parameters in Langendorff-perfused hearts or in vivo. This was associated with increases of SR Ca2+ storage, assessed by caffeine-induced Na+-Ca2+ exchanger currents. The inactivation time of the L-type Ca2+ current (ICa) which has an inverse correlation with Ca2+-induced SR Ca 2+ release, and the relation between the peak current density and half-inactivation time were also normalized, indicating a restoration in the ability of ICa to trigger SR Ca2+ release. The prolonged action potentials in calsequestrin overexpressing cardiomyocytes also reversed to normal upon phospholamban ablation. Furthermore, ablation of phospholamban restored the expression levels of atrial natriuretic factor and α-skeletal actin mRNA as well as ventricular myocyte size. These results indicate that attenuation of phospholamban function may prevent or overcome functional and remodeling defects in hypertrophied hearts.

AB - Cardiac-specific overexpression of murine cardiac calsequestrin results in depressed cardiac contractile parameters, low Ca2+-induced Ca 2+ release from sarcoplasmic reticulum (SR) and cardiac hypertrophy in transgenic mice. To test the hypothesis that inhibition of phospholamban activity may rescue some of these phenotypic alterations, the calsequestrin overexpressing mice were cross-bred with phospholamban-knockout mice. Phospholamban ablation in calsequestrin overexpressing mice led to reversal of the depressed cardiac contractile parameters in Langendorff-perfused hearts or in vivo. This was associated with increases of SR Ca2+ storage, assessed by caffeine-induced Na+-Ca2+ exchanger currents. The inactivation time of the L-type Ca2+ current (ICa) which has an inverse correlation with Ca2+-induced SR Ca 2+ release, and the relation between the peak current density and half-inactivation time were also normalized, indicating a restoration in the ability of ICa to trigger SR Ca2+ release. The prolonged action potentials in calsequestrin overexpressing cardiomyocytes also reversed to normal upon phospholamban ablation. Furthermore, ablation of phospholamban restored the expression levels of atrial natriuretic factor and α-skeletal actin mRNA as well as ventricular myocyte size. These results indicate that attenuation of phospholamban function may prevent or overcome functional and remodeling defects in hypertrophied hearts.

UR - http://www.scopus.com/inward/record.url?scp=0035937762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035937762&partnerID=8YFLogxK

U2 - 10.1074/jbc.M006889200

DO - 10.1074/jbc.M006889200

M3 - Article

C2 - 11115498

AN - SCOPUS:0035937762

VL - 276

SP - 9392

EP - 9399

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 12

ER -